WallStreetZenWallStreetZen

NASDAQ: ARWR
Arrowhead Pharmaceuticals Inc Earnings & Revenue

ARWR past revenue growth

How has ARWR's revenue growth performed historically?
Company
-87%
Industry
82.48%
Market
19.08%
ARWR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ARWR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ARWR's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ARWR earnings and revenue history

Current Revenue
$35.5M
Current Earnings
-$470.8M
Current Profit Margin
-1,327.2%

ARWR Return on Equity

Current Company
-147.1%
Current Industry
16.8%
Current Market
28.2%
ARWR's Return on Equity (-147.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ARWR announces earnings.

ARWR Return on Assets

Current Company
-59.9%
Current Industry
3.2%
ARWR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ARWR Return on Capital Employed

Current Company
-50.37%
Current Industry
-42.4%
ARWR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ARWR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ARWR$35.47M-$432.38M-$470.79M-17.85%N/A
MRUS$38.34M-$156.86M-$149.65M+1.10%N/A
RARE$442.59M-$585.60M-$613.35M+49.64%N/A
DNLI$295.39M-$128.37M-$137.25M+17.35%N/A
CORT$523.53M$122.89M$117.19M+15.17%+11.75%

ARWR earnings dates

Next earnings date
Aug 5, 2024

Arrowhead Pharmaceuticals Earnings & Revenue FAQ

What were ARWR's earnings last quarter?

On Invalid Date, Arrowhead Pharmaceuticals (NASDAQ: ARWR) reported Q1 2024 earnings per share (EPS) of -$1.02, up 321.74% year over year. Total Arrowhead Pharmaceuticals earnings for the quarter were -$125.30 million. In the same quarter last year, Arrowhead Pharmaceuticals's earnings per share (EPS) was $0.46.

If you're new to stock investing, here's how to buy Arrowhead Pharmaceuticals stock.

What was ARWR's earnings growth in the past year?

As of Q2 2024, Arrowhead Pharmaceuticals's earnings has grown year over year. Arrowhead Pharmaceuticals's earnings in the past year totalled -$470.79 million.

What is ARWR's earnings date?

Arrowhead Pharmaceuticals's earnings date is Invalid Date. Add ARWR to your watchlist to be reminded of ARWR's next earnings announcement.

What was ARWR's revenue last quarter?

On Invalid Date, Arrowhead Pharmaceuticals (NASDAQ: ARWR) reported Q1 2024 revenue of $0.00 up 100% year over year. In the same quarter last year, Arrowhead Pharmaceuticals's revenue was $146.27 million.

What was ARWR's revenue growth in the past year?

As of Q2 2024, Arrowhead Pharmaceuticals's revenue has grown -87% year over year. This is 169.48 percentage points lower than the US Biotechnology industry revenue growth rate of 82.48%. Arrowhead Pharmaceuticals's revenue in the past year totalled $35.47 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.